Biotechnology Draws Record Profit as Research Money Slows

Biotechnology Draws Record Profit as Research Money Slows
Biotechnology companies worldwide boosted profit by 37 percent to a record $ 5.2 billion in 2012, partly by tempering growth in research-and-development spending, according to Ernst & Young. Drugmakers led by Amgen Inc. (AMGN) and Gilead Sciences …
Read more on Bloomberg

The Download: Rachel King named chairwoman of Biotechnology Industry
Rachel King, president and chief executive at Gaithersburg-based GlycoMimetics, was chosen last week to serve as board chairwoman of the Biotechnology Industry Organization, the first time a woman has been elected to the post in the trade group's history.
Read more on Washington Post

Biopharmaceutical industry faces a shift in dynamics
As more than 15,000 executives and economic development officials gathered here Monday for the opening day of the annual Biotechnology Industry Organization convention, the talk was less about bringing safe and effective drugs to market than about …
Read more on Boston Globe

Leave a Reply